MAKO misses the mark with weak Q2 robotic system placements
This article was originally published in Clinica
Executive Summary
Shares in robotic surgical systems developer MAKO Surgical took a bashing this week after the company warned that its preliminary second quarter results have revealed that sales during this period will be weaker than expected.